The big challenge for Europe’s investment banks: pick a lane | 欧洲投资银行面临的重大挑战:选择一条赛道。 - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
FT英语电台

The big challenge for Europe’s investment banks: pick a lane
欧洲投资银行面临的重大挑战:选择一条赛道。

There are a lot of ways to make money in investment banking, the mistake is to keep making U-turns
在投资银行业中有很多赚钱的方法,错误在于不断地转向。
00:00

European investment banks have spent years debating the best path to profits. Recent results suggest many roads can work — the more important thing is to pick a lane and stay in it.

BNP Paribas has become the standard-bearer for the traditional investment banker’s argument: large corporates will be more loyal to banks that can be a one-stop shop. A European bank might never be fighting Goldman Sachs for the lead role on a US tech IPO, but it should at least be part of the team when its French client wants to do a secondary listing in New York.

Santander is following suit in trying to build up its investment bank, particularly in the US. Both reported stronger than expected financial results this week.

undefined

HSBC’s new chief executive Georges Elhedery is following a different track, abandoning underperforming businesses such as advising on mergers in Europe and the US. Elhedery is betting that clients know what HSBC is good at: a company that wants to sell stock in Dubai isn’t going to drop HSBC just because it doesn’t have enough M&A bankers in New York.

Backers of the HSBC approach point to the success of American boutiques such as Evercore and PJT Partners — they make no pretence of covering everything, but shares have outperformed full-service players on both sides of the Atlantic over the past few years.

But maybe there is a different lesson to take from the boutiques: they know their role, and, broadly speaking, have stuck to it. There are a lot of ways to make money in investment banking; the mistake is to keep making U-turns then wondering why you haven’t reached the right destination.

HSBC has spent years flip flopping, while Barclays’ attitude has shifted with each chief executive. Deutsche Bank at one point managed five different “strategic plans” in seven years.

Contrast BNP, where Jean-Laurent Bonnafé has been in charge for more than 13 years. It was traditionally strong in fixed income, but decided to start building out its equities business in 2016; those efforts have paid off recently, but it took a long time. Investment bank revenues have grown six years in a row — a feat none of its rivals have matched.

undefined

Deutsche’s turnaround only really began when Christian Sewing convinced investors the group was genuinely committed to a major overhaul — including shedding its equities trading business. Barclays has settled on a very different strategy, but has likewise been rewarded by investors for a perception of stability under chief CS Venkatakrishnan after years of back and forth.

Elhedery has acted quickly since taking charge of HSBC last autumn. Decisive moves in either direction are a good start — the challenge will be to stick with them.

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

囤积行为加剧伊朗战争引发的经济损害

随着霍尔木兹海峡的对峙进入第三个月,全球各国政府都在艰难应对同一个难题:如何防止囤积者加剧从汽油到注射器等各类产品的短缺。

FT社评:伊朗战争让各国央行进退两难

如果各国央行过早通过加息来遏制通胀压力,可能令本已受创的经济雪上加霜;如但果按兵不动、观望冲突的进展,又可能贻误时机。

反弹的通胀与不耐烦的特朗普:凯文•沃什面临双重压力

美国参议院本周有望批准这位56岁的金融家接替杰伊•鲍威尔出任美联储主席。

伊朗战争推高燃气价格,印度工人纷纷逃离城市生活

伊朗战争推高了烹饪燃料价格,迫使印度许多务工人员返乡回村。

能源、军火与粮食:特朗普对伊战争日益沉重的代价

这场冲突正波及整个美国经济,造成了数千亿美元的产出损失。

肺纤维化生物科技公司Avalyn Pharma申请首次公开募股(IPO)

一家生物技术公司正开发可吸入剂型的已获批肺纤维化口服药,计划赴公开市场融资以支持其后期研发。
2天前
设置字号×
最小
较小
默认
较大
最大
分享×